New possibilities for the therapy of secondary progressive multiple sclerosis by A. M. Petrov, E. V. Ivashkova, I. D. Stolyarov

Get full text

Current ethical issues of clinical trials of drugs for the pathogenetic therapy of multiple sclerosis in the context of the COVID-19 pandemic by E. V. Ivashkova, A. M. Petrov, M. V. Votintseva, I. D. Stolyarov

Get full text

Modern ethical aspects of clinical trials in patients with multiple sclerosis by E. V. Ivashkova, A. M. Petrov, M. V. Votintseva, G. G. Shkilnyuk, I. D. Stolyarov

Get full text

Intestinal microbiota composition and peripheral blood Th cell subsets in patients with multiple sclerosis by I. N. Abdurasulova, E. A. Tarasova, I. V. Kudryavtsev, I. G. Negoreeva, A. G. Ilves, M. K. Serebriakova, E. I. Ermolenko, E. V. Ivashkova, A. V. Matsulevich, A. E. Tatarinov, I. D. Stoliarov, V. M. Klimenko, A. N. Suvorov

Get full text